Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zometa granted positive opinion from CPMP

Jan. 9, 2001

Four-year PROactive study examines effects of Actos on cardiovascular risk

Jan. 9, 2001

Phase II IDEC-131 study begins in patients with ITP

Jan. 8, 2001

Positive final results emerge from INS-1 trial for type 2 diabetes

Jan. 8, 2001

BioMarin's rhASB designated an orphan drug in Europe for MPS-VI

Jan. 5, 2001

Major advances in infertility treatment announced by Serono

Jan. 5, 2001

Long-term effects of isobutyramide in beta-thalassemia

Jan. 5, 2001

Potential role for betacellulin in endocrine pancreas function and diabetes

Jan. 5, 2001

Diphenylethylene and styrene derivatives useful for diabetes

Jan. 4, 2001

Skyrin: a mechanistically novel, small-molecule glucagon antagonist

Jan. 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...